News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,974 Results
Type
Article (39066)
Company Profile (279)
Press Release (646629)
Section
Business (203872)
Career Advice (1991)
Deals (35365)
Drug Delivery (86)
Drug Development (80810)
Employer Resources (168)
FDA (16090)
Job Trends (14806)
News (344567)
Policy (32439)
Tag
Academia (2530)
Alliances (49098)
Alzheimer's disease (1235)
Approvals (16025)
Artificial intelligence (134)
Bankruptcy (352)
Best Places to Work (11543)
Biotechnology (200)
Breast cancer (132)
Cancer (1122)
Cardiovascular disease (102)
Career advice (1660)
Cell therapy (238)
Clinical research (64300)
Collaboration (399)
Compensation (202)
COVID-19 (2532)
C-suite (97)
Data (1151)
Diabetes (154)
Diagnostics (6145)
Earnings (84833)
Employer resources (146)
Events (109625)
Executive appointments (318)
FDA (16643)
Funding (361)
Gene therapy (178)
GLP-1 (580)
Government (4326)
Healthcare (18680)
Infectious disease (2617)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16305)
Job creations (3625)
Job search strategy (1417)
Layoffs (413)
Legal (7853)
Lung cancer (171)
Manufacturing (178)
Medical device (13178)
Medtech (13183)
Mergers & acquisitions (19148)
Metabolic disorders (407)
Neuroscience (1516)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1506)
Obesity (234)
Opinion (179)
Patents (105)
People (56294)
Phase I (19971)
Phase II (28321)
Phase III (21117)
Pipeline (467)
Postmarket research (2554)
Preclinical (8501)
Radiopharmaceuticals (236)
Rare diseases (224)
Real estate (5890)
Regulatory (21540)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1319)
Startups (3562)
United States (13734)
Vaccines (551)
Weight loss (169)
Date
Today (126)
Last 7 days (616)
Last 30 days (3665)
Last 365 days (35797)
2024 (33069)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54088)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37554)
2014 (31320)
2013 (26345)
2012 (28572)
2011 (29264)
2010 (27328)
Location
Africa (713)
Arizona (193)
Asia (37152)
Australia (6062)
California (3389)
Canada (1312)
China (256)
Colorado (150)
Connecticut (156)
Europe (79541)
Florida (471)
Georgia (121)
Illinois (347)
Indiana (198)
Kansas (96)
Maryland (586)
Massachusetts (2658)
Michigan (159)
Minnesota (276)
New Jersey (976)
New York (978)
North Carolina (710)
Northern California (1506)
Ohio (139)
Pennsylvania (856)
South America (1091)
Southern California (1319)
Texas (488)
Utah (91)
Washington State (367)
685,974 Results for "nitto denko avecia inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Nitto Acquires Bend Labs, Inc. in the United States
Nitto Denko Corporation (headquarter: Osaka, Japan, President: Hideo Takasaki, hereafter Nitto) (TOKYO:6988) and Bend Labs, Inc. (US, Co-CEO: Jared Jonas, Colton Ottley, hereafter “Bend”) have agreed on Nitto’s acquisition of Bend.
June 1, 2022
·
2 min read
Nitto Strengthens Oligonucleotide Therapeutic Manufacturing Business
In response to the rapid market expansion of oligonucleotide therapeutics that have potential to treat both common and intractable diseases, Nitto Denko Corporation (Headquarters: Osaka; President: Hideo Takasaki; referred to hereafter as “Nitto”) will invest approximately 25 billion Japanese yen in Nitto Denko Avecia Inc.
March 31, 2021
·
3 min read
Business
New President Appointed for Nitto Avecia Inc.
Nitto Denko Avecia Inc. announced today that Detlef Rethage will step down from the position of President of Nitto Denko Avecia Inc., effective July 16, 2018.
August 3, 2018
·
2 min read
Business
n-Lorem Foundation Announces Partnership with Nitto Avecia to Strengthen Development of Personalized Medicines for Patients with Ultra-Rare Diseases
n-Lorem Foundation, a nonprofit organization that provides free, lifetime supplies of individualized RNA-targeted medicines to patients with ultra-rare diseases, today announced a new partnership with Nitto Avecia, the world’s largest oligonucleotide therapeutics manufacturer.
June 16, 2021
·
4 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Genetown
Nitto Denko Avecia Inc. Announces Multiple Oligonucleotide Expansions
November 14, 2016
·
3 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Immunic, Inc. to Participate in Investor Conference in December
November 26, 2024
·
5 min read
Press Releases
Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
November 25, 2024
·
5 min read
1 of 68,598
Next
